Navigation Links
Executive Board Member of National Patient Advocate Foundation, Patient Advocate Foundation Receives National Institutes of Health 2008 Health Disparities Excellence Award
Date:2/10/2009

Lovell Jones, PhD, Director of the Center for Research on Minority Health at M.D. Anderson Cancer Center and Executive Board Member for NPAF and PAF, Honored for His Contributions Toward Eliminating Health Disparities in Minority Communities

WASHINGTON, Feb. 10 /PRNewswire-USNewswire/ -- The National Patient Advocate Foundation (NPAF) and Patient Advocate Foundation (PAF) announced today that a member of the Foundations' Executive Boards, Lovell Jones, PhD, Professor of Health Disparities Research and Director of the Center for Research on Minority Health at the University of Texas M.D. Anderson Cancer Center, was honored with the National Institutes of Health's (NIH) 2008 Health Disparities Excellence Award, which recognizes pioneers for their contributions toward eliminating health disparities in minority communities. Jones was one of two recipients for the 2008 honor.

"We are extremely pleased to see this well-deserved recognition of Lovell's work in advancing minority health, which is making a significant, positive impact on the millions of ethnic minorities in our country who are diagnosed and struggling with their treatment of cancer and other chronic illnesses," said Nancy Davenport-Ennis, Founder and CEO of NPAF and PAF. "Our professional case managers are contacted each day by far too many individuals of all ethnic backgrounds who are facing access to care challenges, and we commend Dr. Jones' important, groundbreaking research in getting to the root of how we as a nation can work together to improve medical care for all patients in need."

Jones' recent studies include examining the correlation of diet and breast cancer recurrence in cancer survivors, including the risk of breast cancer in pre-menopausal African American women, and the relationship between environment and genetics in the development of diseases in migrant workers' children. This research is helping to further educate researchers and physicians about the treatment of chronic diseases in different populations, as well as to help shape public policy in the way health disparities are addressed.

Jones has more than 25 years' experience at M.D. Anderson, and has also served in a variety of scientific, health disparities and cancer research roles. He is the founding co-chair of the Intercultural Cancer Council, the nation's largest multicultural health policy group focused on minorities, and the founding chair of "Minorities, the Medically Underserved and Cancer," the nation's largest multicultural conference providing a forum for exchanging the latest scientific and treatment information. Jones has also served on the Board of Directors of the National Coalition for Cancer Survivorship, the National Advisory Environmental Health Sciences Council of the NIH, and the Prostate Health Council of the American Foundation for Urologic Diseases. In addition to serving on the Executive Boards of NPAF and PAF, Jones currently serves on the Advisory Council for The Benjamin Banneker Institute for Science and Technology and the Partnership for Prevention, as well as a number of other national advisory committees.

"In our ongoing work advocating for America's patients, NPAF and PAF strive to work closely with our nation's foremost experts representing medical research, front-line care, chronic disease prevention and control, insurance coverage issues, and other matters that are vital to understanding how to improve access to care for all patients," said Davenport-Ennis. "We are incredibly proud to work with Lovell and call him our partner in these efforts, and we commend his tremendous work on behalf of cancer patients today and every day."

About the National Patient Advocate Foundation

National Patient Advocate Foundation (NPAF) is a national, non-profit organization that is dedicated to the mission of creating avenues of patient access through improved access to, and reimbursement for, evolving therapies, therapeutic agents, and devices through policy and legislative reform at the state and federal levels. Our mission is shaped by the experiences of the patients served through our companion organization, Patient Advocate Foundation. For more information, visit www.npaf.org.

About the Patient Advocate Foundation

Patient Advocate Foundation is a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases. PAF directly assists patients with chronic and life-threatening conditions who are struggling with access to care issues. Last year, PAF received more than 9.5 million contacts requesting information online, with complete case management mediation and arbitration services provided to 48,800 patients confronting issues denying access to sustained healthcare for their diagnosis of chronic, life-threatening and debilitating conditions. For more information, visit www.patientadvocate.org.


'/>"/>
SOURCE National Patient Advocate Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Physiotherapy Associates Appoints Daniel J. Connors Chief Executive Officer
2. Broadstreet Names Dorian Fabio Executive Vice President of Learning and Performance Improvement
3. Executive Chairman of Medifast Bradley MacDonald Selected to Participate in Leadership Maryland
4. U.S. Preventive Medicine(R) Executives to Present at 2009 UBS Global Healthcare Services Conference
5. Align Technology Executives to Present at ROTH 21st Annual OC Growth Stock Conference
6. Compressus Bolsters Executive Team to Expand Interoperability Market Pioneered by MEDxConnect(TM)
7. Patient-Centered Medical Homes Can Improve Care, Reduce Costs; Independence Blue Cross Medical Executive Discusses Innovative PA Program With Nations Health Care Policy Makers
8. Access MediQuip Appoints Executive Vice President of Payor Sales and Services
9. Julie L. Novak Named Executive Director of Michigan State Medical Society
10. Osteotech Expands Senior Management Team; New Executives to Drive Sales Force Strategies and Therapy-Based Solutions
11. Pelosi Statement on Obama Executive Order Repealing Global Gag Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing LLC announces ... and explore the world from different perspectives. By providing a place for people ... understanding, increase empathy, and find greater happiness. , "Our approach to structuring ...
(Date:2/23/2017)... ... (PRWEB) ... opportunity for the nation to come together to combine its ... – with its favorite fruit – apples! To celebrate National ... to join the “Apple Madness” bracket tournament – a five-week, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Thomas Vas-Don ... and disciplined exercise regime, the author was able to successfully recover. In “ Origin ... relevant information for various sources on the principals of massage, anatomy , ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem ... recent years. The technology is so cutting edge, in fact, the U.S. Food ... stem cell procedures. However, successful patient outcomes in certain clinical stem cell procedures ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes customized ... room, fewer hospital admissions, and better blood pressure and glycemic control, a ... study can be found here . , The study comes as health ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 Tillotts Pharma is ... Berlin office was opened in January ... The portfolio includes Entocort ® for the treatment ... of ulcerative colitis, and VistaPrep ® for bowel ... specialty pharmaceutical company focused on the treatment of gastrointestinal ...
(Date:2/23/2017)... MabVax Therapeutics Holdings, Inc . ... announces that it has received notice from the ... initiation a Phase I clinical trial with MVT-1075 ... ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel fully ... the phase I clinical trial in patients with ...
(Date:2/23/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ( ... and dermatology biopharmaceutical company, today announced that it has ... as special advisers to the Company,s Board of ... board on financial and corporate strategy. Provectus ... of up to $2.5 million from Eric Wachter ...
Breaking Medicine Technology: